Having gained many years' experience in business journalism, Joseph joined Informa in 2007, reporting on the medical technology space. He joined Animal Pharm, rising to become editor and taking the publication online only.
Joseph also launched a series of well-received webinars. As author of a top-selling industry report, he detailed the leading companies in the animal health sector. Since becoming editor, he has transformed Animal Pharm from just a news provider into a more in-depth analytical service.
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Joseph Harvey
Evonik Industries has recently made some significant moves to add to its animal nutrition business and build its capabilities in supporting on-farm monitoring. Animal Pharm editor Joseph Harvey spoke to the firm about why it is making a play in this burgeoning space.
Phibro believes its antibiotics business will continue to grow by 2-4% annually, while sales shift over to more therapeutic use.
In recent years, Evonik Industries has increased its presence in the area of animal probiotics. The company believes good science can set it aside from its competitors in a global market becoming more attuned to animal welfare and food safety. Animal Pharm editor Joseph Harvey met a team of experts from the firm at its headquarters in Germany to find out more.
Elanco's recent spending spree has built on its expertise as a late-stage developer of new products, according to Jeff Simmons.
Jenny Winter took over the reins of UK firm Animalcare around 10 months ago, bringing expertise from the human healthcare space. Animal Pharm editor Joseph Harvey met the chief executive in London to discuss the firm's strategy, its aspirations for growth and her initial thoughts on the wider animal health sector.
French firm Inalve aims to secure investment and begin commercializing its alternative fish feed in 2020.